详情介绍
公司：www.apotech.com
Apotech 公司在瑞士的日内瓦，成立于2000年，供应生命科学用的试剂，其创新的试剂盒产品广泛应用于细胞凋亡，免疫，神经科学信号转导和炎症等领域，并得到了广泛的认可，成功地为其塑造了认可的Apotech的品牌形象，同时Apotech的高质量重组蛋白和抗体也是*的高质量产品，这些都为确立了Apotech在该领域中的。
Highest Standards for Research Kits™
APOTECH Corporation is a worldwide producer and distributor of life science reagents. ApoTech is a leading supplier of new & innovative research kits and sets in the field of apoptosis, immunology and inflammation.
Research kits and sets available from ApoTech include:
- Omentin Detection Set
- L-33, Soluble Detection Set
- TL1A, Soluble Detection Set
- BAFF, Soluble Detection Set and ELISA Kit
- LAG-3, Soluble Detection Set
- totalRANKL, Soluble ELISA Kit
- CTRP7 Detection Set
- TLR Ligands Set I
ApoTech also offer custom services including:
- Rapid labelling service for proteins and antibodies with fluorescent dyes, biotin or HRP
- Custom production （to mg scale） of proteins in different systems
- Customised analysis of molecules for measurement in its ability to induce apoptosis and the mode of action
Please contact Sapphire Bioscience directly to: - place an order
- enquire about price & availability
- ask for Technical Assistance
|
Apotech® - A Brand of Enzo Life Sciences, Inc.
Highest Standards for Research Kits™.
APOTECH Corporation was founded in 2000 in Geneva, Switzerland. The company is a globally operating life science reagents company discovering, developing and producing innovative research kits and sets in the field of apoptosis, immunology and inflammation. A comprehensive product offering, combined with outstanding technical information supports researchers in the advancement of their science.
Apotech Corporation is the operational headquarters of Apotech®, an internationally recognized brand acknowledged as a leader in producing high quality recombinant proteins and antibodies in key research areas. The successful Apotech® brand of innovative research kits and sets covers the fields of Apoptosis, Cancer Research, Immunology, Neuroscience, Signal Transduction and Oxidative Stress. Selected kits with high potential for human diagnostics applications are outlicensed to specialized companies in the field.
On April 29, 2005 AXXORA Life Sciences Inc. and APOTECH Corporation announced the merger of the two companies. Following this merger the companies continued operating from their respective headquarters in San Diego, CA, USA and Epalinges, Switzerland, and under their current management teams.
The merger has resulted in APOTECH Corporation operating as a new business division of AXXORA Life Sciences Inc., and a member of the AXXORA Platform （www.axxora.com）. APOTECH’s cutting edge product line and know-how in recombinant proteins, antibodies and ELISA kits strengthens the group as a manufacturer and single-source supplier of over 14,000 life science reagents and research kits to researchers worldwide.
Prior to the transaction the two companies had a longstanding successful business relationship through distribution and co-development agreements. The merger has strengthened the company’s ability to provide its customers with superior service, innovative products, and enhanced production capabilities.
